Stephen Mandel
Lone Pine Capital
Stephen Mandel UnitedHealth Group Incorporated stake
total: 294
Lone Pine Capital UNH trades
- Total transactions:
- 28
- New positions:
- 3
- Sold out:
- 3
- Added:
- 9
- Reduced:
- 13
- Held since:
- 2025 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q3
According to 2026 Q1 report, Stephen Mandel doesn't hold any UnitedHealth Group Incorporated (UNH) shares. To date, the estimated cost basis is nearly $311.97 for "buy" trades and estimated average "sell" price is $311.97. Lone Pine Capital first purchased UNH in 2017 Q2, initially acquiring about 1.71M shares. Stephen Mandel later completely sold out the position and invested in UnitedHealth Group Incorporated again in 2025 Q2. Since the initial investment in UnitedHealth Group Incorporated (UNH), Lone Pine Capital has made 27 more transactions.
When did Stephen Mandel sell UnitedHealth Group Incorporated (UNH)?
Stephen Mandel sold off the entire UnitedHealth Group Incorporated (UNH) position in 2025 Q3.
When did Stephen Mandel buy UnitedHealth Group Incorporated (UNH)?
Stephen Mandel first invested in UnitedHealth Group Incorporated (UNH) in 2017 Q2 at the reported quarter-end price of $185.42 per share.
What's the cost basis of Lone Pine Capital's UNH stake?
The estimated cost basis for UnitedHealth Group Incorporated (UNH) stake is around $311.97 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $311.97
- Weighted AVG sell price:
- $311.97
Stephen Mandel's historical trades in UnitedHealth Group Incorporated
28 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$311.97
|
|
-100% (-1,693,347)
|
-3.82%
|
|
2025 Q2
|
3.82%
|
1,693,347
|
$311.97
|
$528,273,464
|
new
|
+3.82%
|
|
2024 Q4
|
0.00%
|
0
|
$584.68
|
|
-100% (-821,880)
|
-3.58%
|
|
2024 Q3
|
3.58%
|
821,880
|
$584.68
|
$480,536,798
|
-12.97% (-122,437)
|
-0.58%
|
|
2024 Q2
|
3.90%
|
944,317
|
$509.26
|
$480,902,875
|
new
|
+3.9%
|
|
2024 Q1
|
0.00%
|
0
|
$526.47
|
|
-100% (-891,167)
|
-4.06%
|
|
2023 Q1
|
3.90%
|
891,167
|
$472.59
|
$421,156,613
|
-16.21% (-172,433)
|
-0.78%
|
|
2022 Q4
|
5.38%
|
1,063,600
|
$530.18
|
$563,899,448
|
+13.21% (+124,144)
|
+0.63%
|
|
2022 Q3
|
4.47%
|
939,456
|
$505.04
|
$474,463,000
|
+17.39% (+139,144)
|
+0.66%
|
|
2022 Q2
|
3.88%
|
800,312
|
$513.63
|
$411,064,000
|
-7.54% (-65,266)
|
-0.2%
|
|
2022 Q1
|
2.63%
|
$509.97
|
-62.30% (-1,430,509)
|
|||
|
2021 Q4
|
4.72%
|
$502.14
|
-23.62% (-709,903)
|
|||
|
2021 Q2
|
3.88%
|
$400.44
|
-4.47% (-140,584)
|
|||
|
2021 Q1
|
4.25%
|
$372.07
|
-1.05% (-33,446)
|
|||
|
2020 Q4
|
4.05%
|
$350.68
|
-19.42% (-766,411)
|
|||
|
2020 Q3
|
5.28%
|
$311.77
|
+30.50% (+922,392)
|
|||
|
2020 Q2
|
4.58%
|
$294.95
|
-34.46% (-1,589,932)
|
|||
|
2020 Q1
|
7.00%
|
$249.38
|
+8.74% (+370,917)
|
|||
|
2019 Q4
|
6.68%
|
$293.98
|
-6.31% (-285,800)
|
|||
|
2019 Q3
|
5.79%
|
$217.32
|
+20.06% (+756,600)
|
|||
|
2019 Q2
|
5.72%
|
$244.01
|
+5.53% (+197,536)
|
|||
|
2018 Q4
|
6.03%
|
$249.12
|
+18.46% (+557,057)
|
|||
|
2018 Q3
|
4.13%
|
$266.04
|
-26.78% (-1,103,754)
|
|||
|
2018 Q2
|
5.35%
|
$245.34
|
-3.13% (-133,000)
|
|||
|
2018 Q1
|
4.61%
|
$214.00
|
+16.83% (+612,852)
|
|||
|
2017 Q4
|
4.19%
|
$220.46
|
-17.29% (-761,163)
|
|||
|
2017 Q3
|
4.25%
|
$195.85
|
+158.17% (+2,697,373)
|
|||
|
2017 Q2
|
1.61%
|
$185.42
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.